Literature DB >> 11035439

Systemic lupus erythematosus associated with moyamoya syndrome.

K M El Ramahi1, H M Al Rayes.   

Abstract

Moyamoya disease is an uncommon clinical entity, characterized by bilateral occlusion of the internal carotid artery and the development of collateral arteries. An 18-year-old Saudi male with systemic lupus erythematosus (SLE) presented with mild right hemiparesis, followed by recurrent ischemic stroke. Cerebral angiography showed bilateral internal carotid artery stenosis associated with the development of collateral circulation (moyamoya vessels). There was no evidence of active SLE or other risk factors for cerebral occlusion, such as antiphospholipid antibody syndrome. Medical and surgical interventions did not influence the poor outcome of the recurrent ischemic insults.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11035439     DOI: 10.1191/096120300678828686

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  12 in total

1.  Dual anca positivity in a child with moyamoya-like cerebral vascular changes: an unusual presentation with sudden homonymous hemianopsia.

Authors:  Hale Sakalli; Esra Baskin; Füsun Alehan; Muhteşem Agıldere; Yonca Aydin Akova; Hakan Caner
Journal:  Rheumatol Int       Date:  2011-08-24       Impact factor: 2.631

Review 2.  Experimental Animal Models for Moyamoya Disease: A Species-Oriented Scoping Review.

Authors:  Lei Cao; Yang Dong; Kaiwen Sun; Dongpeng Li; Hao Wang; Hongwei Li; Bo Yang
Journal:  Front Surg       Date:  2022-07-01

3.  Occlusion of Internal Carotid Artery in Kimura's Disease.

Authors:  Tomonori Tamaki; Node Yoji
Journal:  Case Rep Med       Date:  2010-03-04

4.  Treatment of moyamoya syndrome associated with systemic lupus erythematosus and hypothyroidism in an adult by encephaloduroarteriosynangiosis: a case report.

Authors:  Arata Tomiyama; Hitoshi Kimura; Haruo Nakayama; Hideaki Izukura; Jun-Ichi Harashina; Keisuke Ito; Ken-Ichiro Sato; Morito Hayashi; Norihiko Saito; Takatoshi Sakurai; Yoko Hirata; Kazuya Aoki; Satoshi Iwabuchi
Journal:  Case Rep Med       Date:  2012-08-26

5.  Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development.

Authors:  Wanyang Liu; Daisuke Morito; Seiji Takashima; Yohei Mineharu; Hatasu Kobayashi; Toshiaki Hitomi; Hirokuni Hashikata; Norio Matsuura; Satoru Yamazaki; Atsushi Toyoda; Ken-ichiro Kikuta; Yasushi Takagi; Kouji H Harada; Asao Fujiyama; Roman Herzig; Boris Krischek; Liping Zou; Jeong Eun Kim; Masafumi Kitakaze; Susumu Miyamoto; Kazuhiro Nagata; Nobuo Hashimoto; Akio Koizumi
Journal:  PLoS One       Date:  2011-07-20       Impact factor: 3.240

6.  Moyamoya syndrome occurred in a girl with an inactive systemic lupus erythematosus.

Authors:  Yun-Jin Lee; Gyu Min Yeon; Sang Ook Nam; Su Yung Kim
Journal:  Korean J Pediatr       Date:  2013-12-20

Review 7.  Moyamoya disease and syndromes: from genetics to clinical management.

Authors:  Stéphanie Guey; Elisabeth Tournier-Lasserve; Dominique Hervé; Manoelle Kossorotoff
Journal:  Appl Clin Genet       Date:  2015-02-16

8.  A Patient With Multiple Sclerosis and Coexisting Moyamoya Disease: Why and How.

Authors:  Xiaoli Si; Lingfei Li; Yuanjian Fang; Yaping Yan; Jiali Pu
Journal:  Front Neurol       Date:  2020-10-15       Impact factor: 4.003

9.  Systemic lupus erythematosus associated with familial moyamoya disease.

Authors:  Chang Min Lee; Sang Yeob Lee; Seung Hoon Ryu; Sung Won Lee; Kyung Won Park; Won Tae Chung
Journal:  Korean J Intern Med       Date:  2003-12       Impact factor: 2.884

10.  Moyamoya syndrome as an unusual presenting manifestation of systemic lupus erythematosus in a young woman.

Authors:  Guanen Zhou; Zhongping An; Sankalp Gokhale
Journal:  Med Princ Pract       Date:  2013-08-29       Impact factor: 1.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.